Why AbbVie's Booming 2017 Could Continue in 2018 Post author:Sam Post published:December 14, 2017 Post category:BioPharma Now that 2017 is drawing to an end, though, it’s time to focus on the new year. Source: BioSpace You Might Also Like Theranos' Last Defender Claims Federal Witch Hunt January 19, 2017 Ultragenyx Stock Booms After Burosumab Continues to Impress in Phase III Study December 3, 2017 Alder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025 February 1, 2018
Alder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025 February 1, 2018